September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines of The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up
Author Affiliations & Notes
  • Catherine Jackson
    Unit of Regenerative Medicine, Medical Biochemistry, University of Oslo, Oslo, Norway
  • Behzod Tashbayev
    The Norwegian Dry Eye Clinic,, Oslo, Norway
  • Sten Ræder
    The Norwegian Dry Eye Clinic,, Oslo, Norway
    Synslaser Surgery AS, Oslo, Norway
  • Tor Paaske Utheim
    Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
    Department of Ophthalmology, Vestre Viken Hospital Trust, Drammen, Norway
  • Øygunn Aass Utheim
    Department of Ophthalmology, Oslo University Hospital, Oslo, Norway
  • Aleksandar Stojanovic
    Eye Department, University Hospital North Norway, Tromsø, Norway
    Synslaser Surgery AS, Oslo, Norway
  • Neil S Lagali
    Department of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
  • Darlene A Dartt
    Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Xiangjun Chen
    Synslaser Surgery AS, Oslo, Norway
    The Norwegian Dry Eye Clinic,, Oslo, Norway
  • Footnotes
    Commercial Relationships   Catherine Jackson, None; Behzod Tashbayev, None; Sten Ræder, None; Tor Utheim, None; Øygunn Utheim, None; Aleksandar Stojanovic, None; Neil Lagali, None; Darlene Dartt, None; Xiangjun Chen, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5665. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Catherine Jackson, Behzod Tashbayev, Sten Ræder, Tor Paaske Utheim, Øygunn Aass Utheim, Aleksandar Stojanovic, Neil S Lagali, Darlene A Dartt, Xiangjun Chen; Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines of The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5665.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate treatment effects of the guidelines of The International Workshop on Meibomian Gland Dysfunction (2011) in a large cohort of Norwegian dry eye patients with meibomian gland dysfunction.

Methods : One hundred eight patients with dry eye disease and meibomian gland dysfunction were consecutively included in the study and treated with a stepwise approach according to the Dry Eye Severity Level (DESL). A comprehensive dry eye examination including tear film break-up time (TFBUT; normal value > 10), vital staining (Oxford Grading Scheme; normal value: 0) and dry eye severity level (DESL; 1 – 4 (mild – severe)) was performed at three-month and six-month follow-up visits. Data are presented as mean with standard deviation.

Results : Mean age in the study (n=108) was 52.3±16.2; 31.6% males and 68.4% females. Baseline DESL was 2.15±0.52, TFBUT was 5.52±4.21 and vital staining grade was 1.84±2.29. At the three-month follow-up visit, DESL and vital staining grades had decreased to 1.81±0.49 and 1.13±1.36, respectively (p<0.05 for both), while TFBUT had increased to 7.80±4.67 (p<0.05). The six-month follow-up examination confirmed the treatment effects with decreased DESL at 1.74±0.55 compared to baseline (p<0.05) (unchanged compared to three-month follow-up (p=0.12)), increased TFBUT at 8.70±5.18 compared to both baseline and three-month follow-up (p<0.05), and decreased vital staining grade of 0.97±1.56 compared to baseline (p<0.05) (unchanged compared to three-month follow-up (p=0.70)).

Conclusions : Treatment of dry eye disease in patients with meibomian gland dysfunction according to the guidelines of the International Workshop on Meibomian Gland Dysfunction (2011) was effective at both three and six months follow-up.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×